American Cancer Society funds the lab!
/Katherine’s American Cancer Society Research Scholar Grant was recently funded! The grant will help us better understand metabolic dysregulation early in ovarian tumorigenesis and determine whether metabolic inhibitors can be used in combination with PARP inhibitors to improve ovarian cancer therapy.